EV-D68 has reemerged globally, causing severe respiratory illness and acute flaccid myelitis in children. Viral entry depends on host cell receptors. While sialic acids and heparan sulfate are known to play roles, a new study in ACS Infectious Diseases reveals that EV-D68 can also recognize α2,8-linked disialylated gangliosides such as GD3 and GT1a. Blocking glycolipid biosynthesis reduces infection, highlighting a new aspect of viral entry. Here we walk through the key findings, explore how virus–glycolipid interactions drive entry and uncoating, and show how custom glycolipid synthesis services can help translate receptor discovery into functional validation without getting stuck in synthesis hurdles.
The cell tropism and pathogenic mechanisms of EV-D68 are closely linked to its receptor usage. This section reviews the virus classification, epidemiology, and known receptors, identifies gaps in current understanding, and introduces glycolipids as a novel receptor hypothesis. By comparing receptor preferences among different strains, the importance of sialylated glycolipids in viral entry becomes evident.
EV-D68 belongs to the Picornaviridae family and the Enterovirus genus. Since 2014, it has caused widespread outbreaks worldwide and is associated with neurological complications such as acute flaccid myelitis. Viral entry depends on the recognition of cell surface receptors, which determines tissue tropism, host range, and pathogenicity.
Previously identified EV-D68 receptors include ICAM-5, heparan sulfate, and α2,6-linked sialylated N-glycans. However, their distribution in the respiratory tract and central nervous system does not fully explain the virus's neurotropism. Notably, the central nervous system is rich in sialic acid-containing glycolipids (gangliosides), characterized by α2,8-linked sialic acids, yet their role as enterovirus receptors had not been explored. This study addresses this gap by systematically evaluating the binding of EV-D68 strains from different clades to diverse glycolipid structures.
The study first investigated whether EV-D68 strains from different clades could bind heparan sulfate (HS) using a glycan array with nearly one hundred distinct sulfation patterns. The results revealed a clear distinction between HS-binding and non-binding strains, which was further supported by sequencing and functional assays. Below are the key findings:
Enterovirus-D68 strains carrying a VP1 mutation bind to sulfated glycosaminoglycans1,5
The core innovation of this study is the discovery that EV-D68 can recognize gangliosides containing α2,8-linked sialic acids. This section interprets glycan array screening, glycolipid biosynthesis inhibition, and multivalent ligand neutralization experiments to reveal the specificity and functional relevance of virus–glycolipid interactions.
A glycan array was designed to include α2,3-linked and α2,6-linked N-glycans, as well as gangliosides with α2,3- or α2,8-linked sialic acids. Based on fluorescence binding signals, three distinct phenotypes were identified:
Importantly, ganglioside binding is not restricted to a specific clade. Sequence alignment showed that key amino acids in the sialic acid-binding pocket are highly conserved, indicating broad sialic acid recognition capacity. However, the molecular determinants of ganglioside preference remain unclear.
Enterovirus-D68 strains bind to SIA containing glycolipids2,5
To demonstrate that gangliosides function as entry receptors rather than merely binding ligands, two independent approaches were used.
Glycolipid depletion reduces Enterovirus-D68 replication3,5
The study further compared physical stability and entry mechanisms among strains. Heparan sulfate-binding strains generally showed lower acid stability than the laboratory-adapted Fermon strain, while thermal stability differences were minimal.
In acid-dependence assays using the V-ATPase inhibitor bafilomycin A1, strains B2/039 and B2/947 were largely unaffected, whereas B3/1013 was significantly inhibited. Most ganglioside-preference or dual-preference strains (except B1/2013) were sensitive to bafilomycin A1.
These results indicate that not all heparan sulfate-binding strains utilize acid-independent uncoating, and entry mechanisms vary depending on receptor usage combinations.
Variation in pH and thermostability stability among Enterovirus-D68 strains4,5
While this study clearly demonstrates the critical role of glycolipids as viral receptors, translating such findings into reproducible research outcomes presents several practical challenges.
The glycan array experiments rely on well-defined ganglioside standards such as GD3, GD1c, GT1a, and GQ1b. However, these compounds are present in low abundance in biological samples, making extraction and purification difficult. Batch variability and limited commercial availability further restrict systematic screening of glycolipid subclasses, especially those with varying lipid chain compositions.
Multivalent GM3 and GD3 ligands used in neutralization studies require conjugation of glycan headgroups to multivalent scaffolds such as polyacrylamide or polylysine. This involves complex synthetic steps including glycosylation, linker design, purification, and structural validation. Most virology laboratories lack such synthetic capabilities, limiting independent functional studies.
Although GM1 expression was used as a readout in inhibition experiments, comprehensive evaluation of glycolipid subclasses requires advanced analytical techniques such as TLC or LC–MS. These methods also depend on high-purity standards, making validation of inhibitor specificity challenging.
The study reveals variability in ganglioside preference among EV-D68 strains but does not identify the specific amino acid determinants. Addressing this requires systematic synthesis of glycolipid variants with defined structural changes, combined with mutant viral particles. Such structure–activity studies demand high diversity and scalability in glycolipid synthesis.
In response to the challenges outlined above, BOC Sciences offers a comprehensive, end-to-end solution through its glycolipid synthesis services. By integrating advanced, customizable chemical synthesis capabilities with rigorous quality control and analytical systems, we aim to be a trusted partner in glycolipid receptor identification, viral entry mechanism studies, and antiviral research. This section details our core service capabilities and how they directly address key research bottlenecks.
We provide tailored synthesis of structurally defined glycolipids and analogs with controlled modifications and scalable quantities. These compounds support receptor studies, interaction analysis, and quantitative assays without reliance on limited natural sources. Our workflow emphasizes precise structural control, reproducibility, and flexibility to accommodate diverse research requirements across different experimental systems and sample types.
We offer design and preparation of multivalent glycolipid conjugates and related constructs for interaction and blocking studies, including optional labeling and scaffold attachment. All products are structurally confirmed to ensure reliability in experimental applications. Additional customization options are available to adjust valency, linker composition, and physicochemical properties to better match specific binding or assay conditions and improve experimental performance.
Our services include comprehensive profiling and characterization using LC–MS, TLC, and complementary analytical methods. Structural validation and batch consistency are ensured to support accurate evaluation and reproducible research outcomes. Detailed analytical reporting, method optimization, and comparative analysis across samples further enhance data reliability, enabling confident interpretation of glycolipid composition and structural features.
The identification of disialylated gangliosides as functional receptors and the ability to suppress viral infection through glycolipid biosynthesis interference have expanded insights into enterovirus receptor usage and opened new directions for antiviral research. Converting these complex findings into reproducible results requires strong synthesis and analytical support.
BOC Sciences provides integrated glycolipid solutions, including well-defined ganglioside standards, multivalent constructs, and isotope-labeled compounds, with full support from design to scale-up. Contact our team to discuss your project and move your research forward with targeted, reliable support.
References
